Hostname: page-component-8448b6f56d-sxzjt Total loading time: 0 Render date: 2024-04-17T23:29:34.359Z Has data issue: false hasContentIssue false
  • English
  • Français

Prevention of Methicillin-Resistant Staphylococcus aureus Infection: Is Europe Winning the Fight?

Published online by Cambridge University Press:  02 January 2015

Marc J. Struelens  and
Dominique L. Monnet
Marc J. Struelens*
Affiliation:
Antimicrobial Resistance and Healthcare-Associated Infections, Scientific Advice Unit, European Centre for Disease Prevention and Control, Stockholm, Sweden
Dominique L. Monnet
Affiliation:
Antimicrobial Resistance and Healthcare-Associated Infections, Scientific Advice Unit, European Centre for Disease Prevention and Control, Stockholm, Sweden
*
European Centre for Disease Prevention and Control, Tomtebodavägen 11A, 171 83 Stockholm, Sweden (marc.struelens@ecdc.europa.eu)
Get access Rights & Permissions [Opens in a new window]

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is a common cause of disease across Europe, except for Scandinavian countries and the Netherlands. Recently, MRSA incidence has decreased in many European countries following national interventions, including structural and regulatory changes in health care, promotion of hand hygiene, antibiotic stewardship, and targeted screening, isolation, and decolonization of hospitalized carriers of MRSA.

Type
Supplement Article
Information
Infection Control & Hospital Epidemiology , Volume 31 , Issue S1: Papers from the Fifth Decennial International Conference on Healthcare-Associated Infections , November 2010 , pp. S42 - S44
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.European Antimicrobial Resistance Surveillance System (EARSS). EARSS annual report 2008: on-going surveillance of S. pneumoniae, S. aureus, E. coli, E. faecium, E. faecalis, K. pneumoniae, P. aeruginosa. 2009.Google Scholar
2.European Centre for Disease Prevention and Control (ECDC)/European Medicines Agency (EMEA) Joint Working Group. Technical report. The bacterial challenge: time to react. A call to narrow the gap between multidrug-resistant bacteria in the EU and the development of new antibacterial agents. Stockholm: European Centre for Disease Prevention and Control; 2009:1–54. http://ecdc.europa.eu/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf. Accessed April 22, 2010.Google Scholar
3.Bartels, MD, Kristoffersen, K, Boye, K, Westh, H. Rise and subsequent decline of community-associated methicillin resistant Staphylococcus aureus ST30-IVc in Copenhagen, Denmark through an effective search and destroy policy. Clin Microbiol Infect 2010;16(1):78–83.CrossRefGoogle ScholarPubMed
4.Grundmann, H, Aanensen, DM, van den Wijngaard, CC, et al; European Staphylococcal Reference Laboratory Working Group. Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: a molecular-epidemiological analysis. PLoS Med 2010;7(1):e1000215.CrossRefGoogle Scholar
5.Mears, A, White, A, Cookson, B, et al.Healthcare-associated infection in acute hospitals: which interventions are effective? J Hasp Infect 2009;71(4):307–313.CrossRefGoogle ScholarPubMed
6.Carlet, J, Astagneau, P, Brun-Buisson, C, et al.French national program for prevention of healthcare-associated infections and antimicrobial resistance, 1992–2008: positive trends, but perseverance needed. Infect Control Hosp Epidemiol 2009;30(8):737–745.CrossRefGoogle ScholarPubMed
7.Goossens, H, Coenen, S, Costers, M, et al.Achievements of the Belgian Antibiotic Policy Coordination Committee (BAPCOC). Euro Surveill 2008;13(46):19036Google Scholar
8.Grammatico-Guillon, L, Thiolet, JM, Bernillon, P, Coignard, B, Khoshnood, B, Desenclos, JC. Relationship between the prevalence of methicillin-resistant Staphylococcus aureus infection and indicators of nosocomial infection control measures: a population-based study in French hospitals. Infect Control Hosp Epidemiol 2009;30(9):861–869.CrossRefGoogle Scholar
9.MacKenzie, FM, Bruce, J, Struelens, MJ, et al; ARPAC Steering Group. Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus in European hospitals. Clin Microbiol Infect 2007;13(3):269–276.CrossRefGoogle ScholarPubMed
10.van Loo, I, Huijsdens, X, Tiemersma, E, et al.Emergence of methicillin-resistant Staphylococcus aureus of animal origin in humans. Emerg Infect Dis 2007;13(12):1834–1839.CrossRefGoogle ScholarPubMed